These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9236819)

  • 41. Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution.
    De Sole G
    Trans R Soc Trop Med Hyg; 1995; 89(2):224-5. PubMed ID: 7778156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Onchocerciasis in Imo state, Nigeria (2): the prevalence, intensity and distribution in the upper Imo river basin.
    Dozie I; Onwuliri C; Nwoke B
    Int J Environ Health Res; 2004 Oct; 14(5):359-69. PubMed ID: 15385215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Onchodermatitis: Where Are We Now?
    Murdoch ME
    Trop Med Infect Dis; 2018 Sep; 3(3):. PubMed ID: 30274490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of onchocerciasis in Blue Nile valley of western Ethiopia.
    Jira C
    Indian J Public Health; 1993; 37(4):135-7. PubMed ID: 8077003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parasitologic survey of onchocerciasis (river blindness) in Babana District, Kwara State, Nigeria.
    Edungbola LD; Asaolu SO
    Am J Trop Med Hyg; 1984 Nov; 33(6):1147-54. PubMed ID: 6507727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology and psycho-social aspects of onchocercal skin diseases in northeastern Nigeria.
    Okoye IC; Onwuliri CO
    Filaria J; 2007 Dec; 6():15. PubMed ID: 18053165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Onchocerciasis as a risk factor for night blindness.
    Babalola OE
    Ophthalmic Epidemiol; 2012 Aug; 19(4):204-10. PubMed ID: 22775275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Onchocerciasis in the Benue State of Nigeria. IV. The prevalence of the disease among the population in Manor.
    Dipeolu OO; Gemade EI
    Int J Zoonoses; 1983 Jun; 10(1):85-95. PubMed ID: 6642907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
    Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
    Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local knowledge and attitudes about onchocerciasis in Oji-River local government area of Enugu State, Nigeria.
    Manafa OU; Isamah AN
    Epidemiol Infect; 2002 Dec; 129(3):629-33. PubMed ID: 12558348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Onchocerciasis in Ecuador. III. Clinical manifestations of the disease in the province of Esmeraldas.
    Guderian RH; Molea J; Carrillo R; Proaño R; Swanson WL
    Trans R Soc Trop Med Hyg; 1984; 78(1):81-5. PubMed ID: 6710579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis.
    Abiose A; Murdoch I; Babalola O; Cousens S; Liman I; Onyema J; Evans J; Gregory W; Jones B
    Br J Ophthalmol; 1994 Jan; 78(1):8-13. PubMed ID: 8110711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Onchocerciasis in Ecuador. II. Epidemiology of the endemic foci in the province of Esmeraldas.
    Guderian RH; Swanson D; Carrillo R; Proaño R; Molea J; Swanson WL
    Tropenmed Parasitol; 1983 Sep; 34(3):149-54. PubMed ID: 6636296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
    Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
    Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human onchocerciasis: current assessment of the disease burden in Nigeria by rapid epidemiological mapping.
    Gemade EI; Jiya JY; Nwoke BE; Ogunba EO; Edeghere H; Akoh JI; Omojola A
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S79-83. PubMed ID: 9861272
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
    Sam-Wobo SO; Adeleke MA; Jayeola OA; Adeyi AO; Oluwole AS; Ikenga M; Lawniye F; Gazama J; Kagni A; Kosoko TO; Agbeyangi O; Bankole S; Toé L; Mafiana CF; Yameogo L
    J Vector Borne Dis; 2012 Jun; 49(2):101-4. PubMed ID: 22898482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.